New preprint: overcoming the accuracy-generalization tradeoff in docking and scoring for prospective virtual screening. Read the paper
Full-stack access to our model suite applied to your target. Multi-year engagement, program milestones, optional IP co-ownership.
Subscription access to Balto AI and DO Patent for teams with existing computational capability. Free trial on-ramp.
Selected assets from our internal validation pipeline available for out-licensing or co-development. Lead asset: GPR75.
The unified workspace we’re building toward. DO Studio is today’s starting point.
The full discovery suite in plain English. Just describe what you need.
A visual interface for advanced workflows. Precision without the command line.
Build your own drug discovery workflows. No configuration, no DevOps.
Convert PDFs into accurate, editable molecular structures instantly.
Pose prediction and virtual screening with state-of-the-art accuracy.
Production-grade binding affinity predictions for lead optimization.
Get started with Deep Origin's computational drug discovery platform.